表紙
市場調査レポート

ペースメーカーおよび心臓再同期療法用ペースメーカー(CRT-P):世界のパイプライン評価・競争環境・2017年までの市場予測

Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

発行 GlobalData 商品コード 223331
出版日 ページ情報 英文 108 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
ペースメーカーおよび心臓再同期療法用ペースメーカー(CRT-P):世界のパイプライン評価・競争環境・2017年までの市場予測 Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
出版日: 2011年10月31日 ページ情報: 英文 108 Pages
概要

当レポートでは、ペースメーカーおよび心臓再同期療法用ペースメーカー(CRT-P)の世界市場について分析し、関連する疾患(心不整脈・うっ血性心不全)の特徴、製品の機能と特徴、全世界および主要12カ国における販売収益実績額・予測額(2003-2017年)、主要企業・主な市販製品のプロファイル、製品のパイプライン評価、主な資本取引情報などの情報を盛り込んで、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクションと概要

  • イントロダクション
  • 当レポートの構成

第3章 疾患の概要:心不整脈およびうっ血性心不全(CHF)

  • 心不整脈
  • うっ血性心不全(CHF)
  • 心不整脈およびうっ血性心不全の診断
  • 心不整脈およびうっ血性心不全の治療オプション

第4章 機器の概要

  • ペースメーカー:設計とリスク要因
  • 心臓再同期療法用ペースメーカー(CRT-P):設計とリスク要因
  • ペースメーカー・CRT-Pの機能に干渉するデバイス

第5章 市場の特徴

  • 市場収益実績値(全世界、2003-2010年)
  • 市場収益予測値(全世界、2010-2017年)
  • 市場の主な傾向
    • 途上国での販売状況:単心房用ペースメーカーが複心房用よりも売上が大きい
  • 市場のダイナミクス:市場促進・抑制要因

第6章 各国の市場収益実績値・予測値(2003-2017年

  • 市場収益実績値:米国(2003-2010年)
  • 市場収益予測値:米国(2010-2017年)
  • 市場収益実績値:カナダ(2003-2010年)
  • 市場収益予測値:カナダ(2010-2017年)
  • 市場収益実績値:英国(2003-2010年)
  • 市場収益予測値:英国(2010-2017年)
  • 市場収益実績値:フランス(2003-2010年)
  • 市場収益予測値:フランス(2010-2017年)
  • 市場収益実績値:ドイツ(2003-2010年)
  • 市場収益予測値:ドイツ(2010-2017年)
  • 市場収益実績値:イタリア(2003-2010年)
  • 市場収益予測値:イタリア(2010-2017年)
  • 市場収益実績値:スペイン(2003-2010年)
  • 市場収益予測値:スペイン(2010-2017年)
  • 市場収益実績値:日本(2003-2010年)
  • 市場収益予測値:日本(2010-2017年)
  • 市場収益実績値:中国(2003-2010年)
  • 市場収益予測値:中国(2010-2017年)
  • 市場収益実績値:インド(2003-2010年)
  • 市場収益予測値:インド(2010-2017年)
  • 市場収益実績値:オーストラリア(2003-2010年)
  • 市場収益予測値:オーストラリア(2010-2017年)
  • 市場収益実績値:ブラジル(2003-2010年)
  • 市場収益予測値:ブラジル(2010-2017年)

第7章 戦略的競合企業評価

  • 主な市場参加企業
    • Medtronic Inc.
    • St. Jude Medical
    • BIOTRONIK Inc. GMBH
    • Boston Scientific
    • Sorin S.p.A

第8章 主な市販製品:特徴と利点

  • Adapta, Dual Chamber Pacemaker (Medtronic Inc.)
  • EnRythm, Dual Chamber Pacemaker (Medtronic Inc.)
  • Revo MRI SureScan, MRI Safe Dual Chamber Pacemaker (Medtronic Inc.)
  • Advisa MRI SureScan Pacemaker, Dual Chamber MRI Safe Pacemaker (Medtronic Inc.)
  • Accent Wireless Single/Dual Chamber Pacemaker (St. Jude Medical)
  • Entity Dual Chamber Pacemaker (St. Jude Medical)
  • Affinity Dual Chamber Pacemaker (St. Jude Medical)
  • Identity ADx Dual Chamber Pacemaker (St. Jude Medical)
  • Verity ADx Dual Chamber Pacemaker (St. Jude Medical)
  • Regency Single Chamber Pacemaker (St. Jude Medical)
  • Microny Single Chamber Pacemaker (St. Jude Medical)
  • Integrity ADx Dual Chamber Pacemaker (St. Jude Medical)
  • Altrua Group of Single/Dual Chamber Pacemaker (Boston Scientific)
  • ProMRI MRI Safe Single/Dual Chamber Pacemaker (BIOTRONIK)
  • Evia Single/Dual Chamber Pacemaker (BIOTRONIK)
  • Effecta Dual Chamber Pacemaker (BIOTRONIK)
  • Consulta (Medtronic Inc.)
  • Syncra (Medtronic Inc.)
  • Frontier-II (St. Jude Medical)
  • Stratos LV-T (BIOTRONIK)

第9章 戦略的パイプライン評価

  • 治験中のペースメーカー
    • Advisa DR MRI SureScan Pacing System, Medtronic, Inc.
    • ECN Pacemaker, Mathematical Bio-Solutions, Inc.
    • Reply MRI Pacemaker, Sorin Group
    • Ensura MRI SureScan Pacing System, Medtronic, Inc.
    • Unconditional MRI Compatible Implantable Pacemaker, Kenergy Inc.
    • Accent MRI Pacemaker, St. Jude Medical
    • INGENIO 2 PG - MICS, Boston Scientific Corporation
  • 初期開発段階のペースメーカー
    • MicroPort Pacemaker, MicroPort Scientific Corporation
  • 承認段階のペースメーカー
    • INGENIO Pacemaker System NG, Boston Scientific Corporation
  • 治験前段階のペースメーカー
    • Aortic Pacemaker

第10章 戦略的取引分析

  • ベンチャーキャピタル融資(2006-2011年)
  • 企業合併・買収(M&A)取引(2006-2011年)
  • パートナーシップ(2006-2011年)
  • 主な取引

第11章 付録

図表一覧

目次
Product Code: GDME0113MAR

Summary

GlobalData's new report, "Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides the market landscape, competitive landscape and market trend information on the pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides comprehensive information on the key trends affecting the market and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include dual chamber and single chamber pacemakers and cardiac resynchronization therapy-pacemakers.
  • Annualized market revenues data from 2003 to 2010, forecast to 2017 and company share data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the pacemakers and cardiac resynchronization therapy pacemakers market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the pacemakers and cardiac resynchronization therapy pacemakers market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the pacemakers and cardiac resynchronization therapy-pacemakers market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global pacemakers and cardiac resynchronization therapy pacemakers market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction and Overview

  • 2.1. Introduction
  • 2.2. GlobalData Report Guidance

3. Disease Overview: Cardiac Arrythmia and Congestive Heart Failure (CHF)

  • 3.1. Cardiac Arrhythmia
    • 3.1.1. Bradycardia
    • 3.1.2. Fibrillation
  • 3.2. Congestive Heart Failure (CHF)
    • 3.2.1. Epidemiology
  • 3.3. Diagnosis of Cardiac Arrythmia and Congestive Heart Failure
    • 3.3.1. Electrocardiography (ECG)
    • 3.3.2. Echocardiogram
    • 3.3.3. Holter Monitor (or Continuous Ambulatory Electrocardiographic Monitor)
    • 3.3.4. Trans-Telephonic Monitor (Event Recorder)
    • 3.3.5. Treadmill Testing
    • 3.3.6. Tilt Table Studies
    • 3.3.7. Electro-Physiologic Testing
    • 3.3.8. Trans-Thoracic Echocardiography (TTE) and Echocardiography
    • 3.3.9. Intra-Cardiac Electro-Physiologic Procedure
    • 3.3.10. Cardiac Catheterization
    • 3.3.11. B-Type Natriuretic Peptide (BNP) Level Test
  • 3.4. Treatment Options for Cardiac Arrythmia and Congestive Heart Failure
    • 3.4.1. Lifestyle Changes
    • 3.4.2. Medications
    • 3.4.3. Invasive Therapies

4. Device Overview

  • 4.1. Pacemakers
    • 4.1.1. Pacemaker Design
    • 4.1.2. Risk Factors Associated with Pacemakers
  • 4.2. Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
    • 4.2.1. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Design
    • 4.2.2. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Risk Factors
  • 4.3. Devices Interfering with the Working of Pacemaker and Cardiac Resynchronization Therapy-Pacemakers (CRT-P)

5. Global Pacemakers and Cardiac Resynchronization Therapy-Pacemakers: Market Characterization

  • 5.1. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Historic, 2003-2010
  • 5.2. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Forecast, 2010-2017
  • 5.3. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Key Trend
    • 5.3.1. Single Chamber Pacemakers Registered Higher Sales than Dual Chamber Pacemakers in Developing Economies
  • 5.4. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics
    • 5.4.1. Market Drivers
    • 5.4.2. Market Restraints

6. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Analysis by Country, Revenue ($m), 2010-2017

  • 6.1. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Historic, 2003-2010
  • 6.2. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Forecast, 2010-2017
  • 6.3. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Historic, 2003-2010
  • 6.4. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Forecast, 2010-2017
  • 6.5. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Historic, 2003-2010
  • 6.6. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Forecast, 2010-2017
  • 6.7. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Historic, 2003-2010
  • 6.8. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Forecast, 2010-2017
  • 6.9. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Historic, 2003-2010
  • 6.10. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Forecast, 2010-2017
  • 6.11. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Historic, 2003-2010
  • 6.12. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Forecast, 2010-2017
  • 6.13. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Historic, 2003-2010
  • 6.14. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Forecast, 2010-2017
  • 6.15. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Historic, 2003-2010
  • 6.16. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Forecast, 2010-2017
  • 6.17. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Historic, 2003-2010
  • 6.18. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Forecast, 2010-2017
  • 6.19. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Historic, 2003-2010
  • 6.20. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Forecast, 2010-2017
  • 6.21. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Historic, 2003-2010
  • 6.22. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Forecast, 2010-2017
  • 6.23. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Historic, 2003-2010
  • 6.24. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Forecast, 2010-2017

7. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market: Strategic Competitive Assessment

  • 7.1. Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants
    • 7.1.1. Medtronic Inc.
    • 7.1.2. St. Jude Medical
    • 7.1.3. BIOTRONIK Inc. GMBH
    • 7.1.4. Boston Scientific
    • 7.1.5. Sorin S.p.A

8. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Key Marketed Products

  • 8.1. Adapta, Dual Chamber Pacemaker, Medtronic Inc.
    • 8.1.1. Features and Benefits
  • 8.2. EnRythm, Dual Chamber Pacemaker, Medtronic Inc.
    • 8.2.1. Features and Benefits
  • 8.3. Revo MRI SureScan, MRI Safe Dual Chamber Pacemaker, Medtronic Inc.
    • 8.3.1. Features and Benefits
  • 8.4. Advisa MRI SureScan Pacemaker, Dual Chamber MRI Safe Pacemaker, Medtronic Inc.
    • 8.4.1. Features and Benefits
  • 8.5. Accent Wireless Single/Dual Chamber Pacemaker, St. Jude Medical
    • 8.5.1. Features and Benefits
  • 8.6. Entity Dual Chamber Pacemaker, St. Jude Medical
    • 8.6.1. Features and Benefits
  • 8.7. Affinity Dual Chamber Pacemaker, St. Jude Medical
    • 8.7.1. Features and Benefits
  • 8.8. Identity ADx Dual Chamber Pacemaker, St. Jude Medical
    • 8.8.1. Features and Benefits
  • 8.9. Verity ADx Dual Chamber Pacemaker, St. Jude Medical
    • 8.9.1. Features and Benefits
  • 8.10. Regency Single Chamber Pacemaker, St. Jude Medical
    • 8.10.1. Features and Benefits
  • 8.11. Microny Single Chamber Pacemaker, St. Jude Medical
    • 8.11.1. Features and Benefits
  • 8.12. Integrity ADx Dual Chamber Pacemaker, St. Jude Medical
    • 8.12.1. Features and Benefits
  • 8.13. Altrua Group of Single/Dual Chamber Pacemaker, Boston Scientific
    • 8.13.1. Features and Benefits
  • 8.14. ProMRI MRI Safe Single/Dual Chamber Pacemaker, BIOTRONIK
    • 8.14.1. Features and Benefits
  • 8.15. Evia Single/Dual Chamber Pacemaker, BIOTRONIK
    • 8.15.1. Features and Benefits
  • 8.16. Effecta Dual Chamber Pacemaker, BIOTRONIK
    • 8.16.1. Features and Benefits
  • 8.17. Consulta, Medtronic Inc.
    • 8.17.1. Features and Benefits
  • 8.18. Syncra, Medtronic Inc.
    • 8.18.1. Features and Benefits
  • 8.19. Frontier-II, St. Jude Medical
    • 8.19.1. Features and Benefits
  • 8.20. Stratos LV-T, BIOTRONIK
    • 8.20.1. Features and Benefits

9. Pacemakers Market: Strategic Pipeline Assessment

  • 9.1. Pacemakers in Clinical Development Stage
    • 9.1.1. Advisa DR MRI SureScan Pacing System, Medtronic, Inc.
    • 9.1.2. ECN Pacemaker, Mathematical Bio-Solutions, Inc.
    • 9.1.3. Reply MRI Pacemaker, Sorin Group
    • 9.1.4. Ensura MRI SureScan Pacing System, Medtronic, Inc.
    • 9.1.5. Unconditional MRI Compatible Implantable Pacemaker, Kenergy Inc.
    • 9.1.6. Accent MRI Pacemaker, St. Jude Medical
    • 9.1.7. INGENIO 2 PG - MICS, Boston Scientific Corporation
  • 9.2. Pacemaker in Early Development Stage
    • 9.2.1. MicroPort Pacemaker, MicroPort Scientific Corporation
  • 9.3. Pacemakers in Approval Phase
    • 9.3.1. INGENIO Pacemaker System NG, Boston Scientific Corporation
  • 9.4. Pacemakers in Pre-Clinical Development Stage
    • 9.4.1. Aortic Pacemaker

10. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Strategic Deals Analysis

  • 10.1. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Venture Financing Deals, 2006-2010
  • 10.2. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Mergers and Acquisitions, 2006-2011
  • 10.3. Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Partnerships, 2006-2011
  • 10.4. Key Deals
    • 10.4.1. LETI Forms Partnership with Sorin, TIMA, Cedrat Technologies, Tronics and EASII IC
    • 10.4.2. St. Jude Medical to Invest in Nanostim
    • 10.4.3. Boston Scientific Enters into an Agreement with Fukuda Denshi
    • 10.4.4. MediVed to Secure $5m in Second Round of Financing

11. Appendix

  • 11.1. Market Definitions
    • 11.1.1. Pacemakers
    • 11.1.2. Cardiac Resynchronisation Therapy-Pacemakers
  • 11.2. Acronyms
  • 11.3. Sources
  • 11.4. Research Methodology
    • 11.4.1. Secondary Research
    • 11.4.2. Primary Research
    • 11.4.3. Models
    • 11.4.4. Forecasts
    • 11.4.5. Expert Panels
  • 11.5. GlobalData Consulting
  • 11.6. Contact Us
  • 11.7. Disclaimer

List of Tables

  • Table 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010
  • Table 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017
  • Table 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010
  • Table 4: Percentage of Overweight and Obese Population (Aged 15 Years and Above), Global, 2010
  • Table 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010
  • Table 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010
  • Table 7: Percentage of Smoking Population, Global, 2010
  • Table 8: Percentage of Population aged 65 Years and Older, by Country, 2005-2015
  • Table 9: Emerging Market Contribution, Global, 2009-2010
  • Table 10: Demand versus Supply, Developing Economies, 2009
  • Table 11: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010
  • Table 12: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
  • Table 13: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
  • Table 14: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
  • Table 15: Deference of Healthcare Services, The US, 2006-2009
  • Table 16: Cardiac Rhythm Management Market, List of Device Recalls, 2004-2010
  • Table 17: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010
  • Table 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR (2010-2017)
  • Table 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010
  • Table 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017
  • Table 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010
  • Table 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017
  • Table 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010
  • Table 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017
  • Table 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010
  • Table 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017
  • Table 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010
  • Table 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017
  • Table 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010
  • Table 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017
  • Table 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010
  • Table 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017
  • Table 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010
  • Table 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017
  • Table 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010
  • Table 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017
  • Table 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010
  • Table 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017
  • Table 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010
  • Table 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017
  • Table 41: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010
  • Table 42: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017
  • Table 43: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010
  • Table 44: Adapta, Features and Benefits
  • Table 45: EnRythm, Features and Benefits
  • Table 46: Revo MRI SureScan, Features and Benefits
  • Table 47: Advisa MRI SureScan Pacemaker, Features and Benefits
  • Table 48: Accent Wireless Single / Dual Chamber Pacemaker, Features and Benefits
  • Table 49: Entity Dual Chamber Pacemaker, Features and Benefits
  • Table 50: Affinity, Features and Benefits
  • Table 51: Identity ADx, Features and Benefits
  • Table 52: Verity ADx, Features and Benefits
  • Table 53: Regency, Features and Benefits
  • Table 54: Microny, Features and Benefits
  • Table 55: Integrity ADx, Features and Benefits
  • Table 56: Altrua, Features and Benefits
  • Table 57: ProMRI, Features and Benefits
  • Table 58: Evia, Features and Benefits
  • Table 59: Effecta, Features and Benefits
  • Table 60: Consulta, Features and Benefits
  • Table 61: Syncra, Features and Benefits
  • Table 62: Frontier-II, Features and Benefits
  • Table 63: Stratos LV-T, Features and Benefits
  • Table 64: List of Pacemaker in Clinical Development Stage
  • Table 65: Advisa DR MRI SureScan Pacing System, Status
  • Table 66: Advisa DR MRI SureScan Pacing System, Clinical Trial
  • Table 67: Aortic Pacemaker, Status
  • Table 68: Reply MRI Pacemaker, Product Status
  • Table 69: Reply MRI Pacemaker, Clinical Trial
  • Table 70: Ensura MRI SureScan, Status
  • Table 71: Unconditional MRI Compatible Implantable Pacemaker, Status
  • Table 72: Accent MRI Pacemaker, Status
  • Table 73: INGENIO 2 PG - MICS , Status
  • Table 74: List of Pacemaker in Early Development Stage
  • Table 75: MicroPort Pacemaker, Status
  • Table 76: List of Pacemaker in Approval Phase
  • Table 77: INGENIO Pacemaker System NG, Status
  • Table 78: List of Pacemaker in Pre-Clinical Development Stage
  • Table 79: Aortic Pacemaker, Status
  • Table 80: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market
  • Table 81: Pacemaker Market, Venture Financing Deals, 2006-2010
  • Table 82: Pacemaker, Mergers and Acquisitions, 2006-2011
  • Table 83: Pacemaker Market, Partnerships, 2006-2011

List of Figures

  • Figure 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010
  • Figure 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017
  • Figure 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010
  • Figure 4: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics
  • Figure 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010
  • Figure 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010
  • Figure 7: Percentage of Population Aged 65 Years and Above, by Country, 2005-2015
  • Figure 8: Emerging Market Contribution, Global, 2009-2010
  • Figure 9: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010
  • Figure 10: Evolution in Pacemaker Technology and its Impact on the Market
  • Figure 11: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
  • Figure 12: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
  • Figure 13: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010
  • Figure 14: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010
  • Figure 15: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR(2010-2017)
  • Figure 16: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010
  • Figure 17: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017
  • Figure 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010
  • Figure 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017
  • Figure 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010
  • Figure 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017
  • Figure 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010
  • Figure 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017
  • Figure 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010
  • Figure 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017
  • Figure 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010
  • Figure 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017
  • Figure 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010
  • Figure 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017
  • Figure 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010
  • Figure 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017
  • Figure 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010
  • Figure 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017
  • Figure 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010
  • Figure 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017
  • Figure 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010
  • Figure 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017
  • Figure 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010
  • Figure 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017
  • Figure 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010
  • Figure 41: Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants Presence in Market Segments, 2010
  • Figure 42: Medtronic Inc., SWOT Analysis
  • Figure 43: St. Jude Medical, Inc., SWOT Analysis
  • Figure 44: BIOTRONIK , SWOT Analysis
  • Figure 45: Boston Scientific, SWOT Analysis
  • Figure 46: Sorin S.p.A, SWOT Analysis
  • Figure 47: Pacemakers Market, Global Pipeline Products
  • Figure 48: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Deals, 2006-2011
Back to Top